An enzyme-linked immunosorbent assay (ELISA) assay showed that ITGBL1 was significantly higher in the plasma EVs of CRC patients (Fig. 1j), with particularly higher values in patients with distant metastases (Fig. 1k). The gene discussed is ITGBL1; the disease is colorectal carcinoma.